Issued Patents All Time
Showing 26–41 of 41 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9494666 | NMR measurement of clinically relevant ionized biosample constituents such as ionized calcium and/or magnesium | Elias J. Jeyarajah, John Contois, Lili Duan, Qun Zhou, Steve Markham +1 more | 2016-11-15 |
| 9483611 | Protective HDL particle number evaluations | Irina Y. Shalaurova | 2016-11-01 |
| 9483612 | CHD risk stratification evaluations for subjects with high levels of large HDL-P | Irina Y. Shalaurova | 2016-11-01 |
| 9470771 | NMR measurements of NMR biomarker GlycA | Irina Y. Shalaurova, Dennis W. Bennett, Justyna E. Wolak-Dinsmore | 2016-10-18 |
| 9435870 | Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements | — | 2016-09-06 |
| 9361429 | Multi-parameter diabetes risk evaluations | Irina Y. Shalaurova, Dennis W. Bennett, Justyna E. Wolak-Dinsmore, Thomas M. O'Connell, Kelly Mercier | 2016-06-07 |
| 8704521 | NMR analyzers for clinical evaluation of biosamples | Elias J. Jeyarajah, Stephen Markham, Steven P. Matyus, David R. Morgan, Bruce D. Silberman +1 more | 2014-04-22 |
| 8386187 | Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same | — | 2013-02-26 |
| 8013602 | NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples | Elias J. Jeyarajah, Stephen Markham, Steven P. Matyus, David R. Morgan, Bruce D. Silberman +1 more | 2011-09-06 |
| 7790465 | Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements | — | 2010-09-07 |
| 6653140 | Methods for providing personalized lipoprotein-based risk assessments | — | 2003-11-25 |
| 6617167 | Method of determining presence and concentration of lipoprotein X in blood plasma and serum | Elias J. Jeyarajah, Irina Y. Shalaurova | 2003-09-09 |
| 6576471 | Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results | — | 2003-06-10 |
| 6518069 | Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders | Dennis W. Bennett | 2003-02-11 |
| 5343389 | Method and apparatus for measuring classes and subclasses of lipoproteins | — | 1994-08-30 |
| 4933844 | Measurement of blood lipoprotein constituents by analysis of data acquired from an NMR spectrometer | — | 1990-06-12 |